🌟 Découvrez toutes nos offres sur desktop ou tablette !
Autres
Animal Stem Cell Therapy Market to Quadruple to USD 3.8 Bn as Pets Gain Access to Human-Grade Regenerative Medicine
[SAN DIEGO, USA – May 14th, 2025] – The animal stem cell therapy market will grow at 26% CAGR to USD 3.8B by 2031, per a new 340-page ClearView report. Key developments:
Request Sample @ https://clearviewmarketinsights.com/report-details/animal-stem-cell-therapy-market/
Industry Shifts
- Clinical Breakthroughs:
- VetStem’s Canine OA Treatment: 85% of dogs resume play within 8 weeks.
- Magellan’s Equine Amniotic Therapy boasts a 90% return-to-track rate for racehorses.
- Regulatory Momentum:
- FDA’s 2026 approval of first allogeneic stem cell bank for dogs.
- EU bans corticosteroid injections for equine sports injuries (2027).
- Consumer Demand:
- 72% of pet owners choose stem cells over joint surgery (AVMA survey).
- "Stem Cell-Certified" breeding dogs sell at 40% premium.
Executive Quotes
- Dr. Robert Harman, VetStem CEO:
"We’re making hip replacements obsolete for dogs." - Dr. Steven St. Peter, Aratana CEO:
"Our off-the-shelf cells cut treatment costs and wait times in half."
Future Projections
- 2027: First stem cell therapy for feline diabetes.
- 2030: 25% of veterinary clinics offer in-house cell processing.
For more insights, visit https://clearviewmarketinsights.com/
About ClearView Market Insights Analytics
ClearView Market Insights Analytics is a global leader in industrial technology research, offering actionable insights across more than 100 laser market segments.
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369